Followers | 6 |
Posts | 28 |
Boards Moderated | 0 |
Alias Born | 09/18/2013 |
Monday, March 31, 2014 2:34:42 PM
March 31, 2014 Thomas Toland
949-698-8485 mobile
SURGLINE renews its business license and annual list effective March 3, 2014
WEST PALM BEACH, Fla., JANUARY 13, 2014 SurgLine International, Inc. (SGLN.PK)
The company is pleased to announce that it has renewed its business license with the state of Nevada for SurgLine Inc. effective March 31, 2014.
The company is continuing its focus on marketing cost effective surgical implants and related products to its targeted customer base in the U.S. marketplace.
The company's management team believes that adoption of he industry to more cost effective solutions such as generic style pricing is a cornerstone to economic savings to the heathcare system and will continue to pursue those opportunities.
The Company’s model of eliminating unnecessary layers of sales distribution costs will afford it with the opportunity to save our customers 30% on average when compared to the traditional distribution chains while drop shipping these products directly to the customer for quick delivery.
SurgLine has begun to upload its product catalogs into this marketplace and commence sales of those items to thru www.surglinesupplies.com. SurgLine’s traditional product offering will require authentication of the end user in keeping with FDA requirements and will be incorporated into the www.surglinesupplies.com.
McKesson is the registered trademark of McKesson Corporation and Henry Schein is the registered trademark of Henry Schein, Inc.
SurgLine continues to participate in the MedPassage ecosystem and anticipates that the MedPassage ecosystem will continue to gain market share awareness in the coming year to which SurgLine will benefit from sale of its products and aggressive pricing strategies.
Keywords: Henry Schein, McKesson, Medical, Dental, Veterinarian, Hospitals, Clinics, Physician, Practices, Savings, Laboratories, SurgLine, SurgLinesavings.com, Savings, direct ship.
Forward Looking Statements
This update release may contain forward-looking statements, including information about management’s view of future expectations, plans and prospects for SurgLine International, Inc. (the "Company"). In particular, when used in the preceding discussion, the words "predicts", "believes", "expects", "intends", "seeks", "estimates", "plans", "anticipates", and similar conditional expressions or future or conditional verbs such as "will", "may", "might", "should" "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statements as bine expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date of the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that re not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under item, "Risk Factors" of the Company’s annual Report on Form 10-K for the year ended July 31, 2014 and in any of the Company’s other subsequent Securities and Exchange Commission filings.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM